SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

29 Oct 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 115.04 millions as compared to Rs. 149.23 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 80.33 millions grew from Rs.-9.89 millions Operating profit Margin for the quarter ended September 2024 improved to 100.21% as compared to -0.28% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 115.04 149.23 -22.91 237.94 264.67 -10.10 490.89 425.47 15.38
Other Income 101.88 6.92 1372.25 103.26 8.82 1070.75 11.52 11.37 1.32
PBIDT 100.21 -0.28 -35889.29 98.89 -16.24 -708.93 -26.09 -29.97 -12.95
Interest 3.26 4.05 -19.51 7.15 7.53 -5.05 16.34 13.81 18.32
PBDT 96.95 -4.33 -2339.03 91.74 -23.77 -485.95 -42.43 -43.78 -3.08
Depreciation 7.11 6.80 4.56 14.26 13.49 5.71 27.15 23.99 13.17
PBT 89.84 -11.13 -907.19 77.48 -37.26 -307.94 -69.58 -67.77 2.67
TAX 9.51 -1.24 -866.94 9.35 -2.77 -437.55 -0.06 -4.15 -98.55
Deferred Tax 9.51 -1.24 -866.94 9.35 -2.77 -437.55 -0.04 -4.30 -99.07
PAT 80.33 -9.89 -912.23 68.13 -34.49 -297.54 -69.52 -63.62 9.27
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 87.11 -0.19 -46533.26 41.56 -6.14 -777.34 -5.31 -7.04 -24.55

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×